Anetumab Ravtansine
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Anetumab Ravtansine, covering 2019-05-21 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer [Phase 1]